Australia markets closed

Veeva Systems Inc (VEE.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
162.78-0.58 (-0.36%)
At close: 08:00AM CEST
Full screen
Previous close163.36
Bid169.20 x 0
Ask169.84 x 0
Day's range162.78 - 162.78
52-week range145.00 - 226.10
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date30 May 2023 - 05 June 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    More than 100 Biopharmas Increase Impactful Engagement with Veeva CRM Events Management

    Veeva Systems (NYSE: VEEV) today announced more than 100 life sciences companies are using Veeva CRM Events Management to plan and execute in-person, virtual, and hybrid events worldwide. Supporting more than one million medical and commercial events to date, Events Management is helping teams lead more impactful healthcare professional (HCP) and key opinion leader (KOL) education and peer-to-peer interactions across channels.

  • Motley Fool

    Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio

    If you've learned little in your life about the stock market -- which is likely, as financial matters are not always taught in school -- you may be assuming that you need to be at least somewhat wealthy in order to invest in the stock market. Veeva Systems (NYSE: VEEV), with a recent market value topping $27 billion, specializes in cloud-based software that helps companies in various industries -- most notably the life sciences -- operate more efficiently. For example, it helps the pharmaceutical industry manage clinical trials and get them to market faster, when possible.

  • Motley Fool

    A Bull Market Is Coming: 1 Excellent Growth Stock to Buy Now

    Let's consider one such stock: Veeva Systems (NYSE: VEEV). Life sciences companies routinely test brand-new and unproven clinical products or technologies on patients. Veeva Systems offers a range of cloud-based software services, ranging from data storage to clinical trial management, to help life sciences companies remain legally compliant while bringing their products to market faster and more efficiently.